AstraZeneca leaps on cholesterol drug ruling
June 30, 2010 at 04:26 AM EDT
AstraZeneca’s London-listed shares leaped as much as 11% on Wednesday after a judge ruled in favor of the company’s patents on a key cholesterol drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.